Back to News
Market Impact: 0.6

Gentherm Inc. Q2 Profit Decreases, Misses Estimates

THRMNDAQ
Corporate EarningsAnalyst EstimatesCorporate Guidance & OutlookCompany Fundamentals
Gentherm Inc. Q2 Profit Decreases, Misses Estimates

Gentherm Inc. (THRM) reported a significant year-over-year decline in second-quarter earnings, with GAAP net income falling to $0.48 million ($0.02 EPS) from $18.88 million ($0.60 EPS) and adjusted EPS of $0.54 missing Street estimates of $0.58. Revenue for the period also saw a marginal 0.2% decrease to $375.09 million.

Analysis

Gentherm Inc. reported a significant deterioration in second-quarter profitability, with GAAP net income plummeting to $0.48 million, or $0.02 per share, from $18.88 million, or $0.60 per share, in the prior-year period. This sharp decline in earnings occurred despite relatively stable revenue, which decreased by a marginal 0.2% to $375.09 million. The performance also fell short of market expectations on an adjusted basis, as the company's adjusted EPS of $0.54 missed the analyst consensus estimate of $0.58. The stark contrast between flat top-line performance and a near-total collapse in GAAP earnings points to severe margin pressure or a substantial increase in costs not specified in the release. The company has issued full-year revenue guidance between $1.43 billion and $1.5 billion, which will be a key metric for investors to track against this backdrop of declining profitability.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

strongly negative

Sentiment Score

-0.70

Ticker Sentiment

NDAQ0.00
THRM-0.80

Key Decisions for Investors

  • Investors should view the severe contraction in profitability, with GAAP EPS falling from $0.60 to $0.02, as a primary concern, suggesting a need to investigate the drivers of margin erosion before considering new or expanded long positions.
  • Given the miss on adjusted EPS and the strongly negative sentiment, it may be prudent to re-evaluate exposure to THRM, as the market is likely to react negatively to the combination of declining earnings and missed forecasts.
  • The full-year revenue guidance of $1.43–$1.5 billion now serves as a critical benchmark; investors must monitor whether the company can achieve this target while simultaneously addressing the underlying issues that crippled its second-quarter bottom line.